메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

융합의과학과

교수소개

의생명과학 전공 참여교수 및 프로필입니다.

이대호, M.D., Ph.D.
소속 및 직위
소속: 의과대학 의학과   직위: 교수
실험실명
인슐린저항성 연구실
연구분야
내분비대사학, 당뇨병학
연구실위치
가천대학교 이길여암·당뇨연구원 3층 임상교수 연구실
전공분야
당뇨병, 지방간, 비만증, 인슐린저항성/인슐린 신호전
  • +82-32-458-2733
  • drhormone@naver.com
  • 학력 및 경력 


    전남대학교 의과대학/내과전문의 (전남대학교병원)/의학박사 (전남대학교 의과대학)
    내분비대사내과 전임의 (전남대학교병원)
    Harvard Medical School 장기연수(2007-2009)
    제주대학교 의과대학 내과 (조교수-부교수)/원광대학교 의과대학 내과 (교수)
    현재 가천대학교 의과대학, 가천대학교 길병원 내과 교수
    대한당뇨병학회 연구이사(2016~2017), 대한당뇨병학회 학술이사 (2022~2023)

     


    소개

     

    당뇨병 및 비만증의 유병률의 증가로 관련 질환의 기본적인 병태생리연구와 그리고 이 질환과 관련된 합병증 그리고 지방간질환에 연구가 매우 중요한 시점이 되었다. 본 연구실은 이들 질환과 관련된 병태생리 연구, 분자생물학적 연구, 치료약제 기전연구, 유전체 연구 등을 수행하며 주로 중개 및 임상연구를 수행하고 있다. 또한 관련된 임상연구와 빅데이터 연구 등을 통해서 임상근거를 확인하고 진료지침 등의 수립에 참여하고 있다.

     

    키워드

     

    당뇨병, 인슐린저항성, 비만증, 지방간질환

     

     


    최근 연구업적(2018-현재) (교신)

     

    . Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With DiabetesJ Clin Endocrinol Metab.0021-972X (2022) Na, Y

    2. Plasma Metabolomics and Machine Learning-Driven Novel Diagnostic Signature for Non-Alcoholic Steatohepatitis BIOMEDICINES2227-9059 (2022)Ji, M

    3. Plasma and urinary extracellular vesicle microRNAs and their related pathways in diabetic kidney disease GENOMICS 0888-7543(2022) Park, S

    4. Plasma Aldo-Keto Reductase Family 1 Member B10 as a Biomarker Performs Well in the Diagnosis of Nonalcoholic Steatohepatitis and Fibrosis Int J Mol Sci. 1661-6596 (2022)Park, A

    5. A comprehensive evaluation of regression-based drug responsiveness prediction models, using cell viability inhibitory concentrations (IC50 values) BIOINFORMATICS 1367-4803(2022)Park, A

    6. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis. Int J Nanomedicine. 1176-9114 (2021)Shin, MJ

    7. Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease. Diabetes Metab J 2233-6079(2021)Choi, Seung Joon

    8. A Flounder Fish Peptide Shows Anti-Hypertensive Effects by Suppressing the Renin-Angiotensin-Aldosterone System and Endothelin-1 Protein Pept Lett. 0929-8665(2021)Rahmdel, M

    9. Overweight and Obesity Are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study Endocrinol Metab 2093-596X2021지원준

    10. Development of a novel dual reproductive organ on a chip: recapitulating bidirectional endocrine crosstalk between the uterine endometrium and the ovaryBIOFABRICATION1758-5082(2021)Park, SR

    11. Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: A matter of sexual dimorphism?Diabetes Res Clin Pract0168-8227(2020)Huh, K.

    12. Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitusMedicine0025-7974(2020)Cho, E.-H.

    13. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. Diabetes Metab J .2233-6079(2020)이병완

    14. Statins and All-Cause Mortality in Patients Undergoing Hemodialysis J Am Heart Assoc2047-9980(2020)Jung, J

    15. The profiles of microRNAs from urinary extracellular vesicles (EVs) prepared by various isolation methods and their correlation with serum EV microRNAsDiabetes Res Clin Pract0168-82272020Park, S

    16. The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetesDiabetes Res Clin Pract. 0168-8227(2019)Kim, TH

    17. miR2Diabetes: A Literature-Curated Database of microRNA Expression Patterns, in Diabetic Microvascular ComplicationsGENES2073-44252019Park, S

    18. Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosisDiabetes Metab Syndr Obes1178-7007(2019)Lee, K

    19. Reply to Letter to the Editor-Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial InfarctionJ Cardiovasc Pharmacol Ther 1074-2484(2019)Lee, DH

    20. Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjectsDiabetes Metab Syndr Obes1178-70072019Shin, D

    21. Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital DischargeJ Cardiovasc Pharmacol Ther1074-2484(2019)Choi, IS

    22. Association between Bone Mineral Density and Albuminuria: Cross-Sectional Analysis of Data from the 2011 Korea National Health and Nutrition Examination Survey V-2Endocrinol Metab2093-596X(2018)Yu, TY

    23. Statin has more protective effects in AMI patients with higher plasma BNP or NT-proBNP level, but not with lower left ventricular ejection fractionJOURNAL OF CARDIOLOGY0914-5087(2018)Cho, J

    24. SPARTA: super-fast permutation approach to approximate extremely low p-valuesINTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS1748-5673(2018)Leem, S